Pooled Analysis on the Efficacy of the Second-line Treatment Regimens for Helicobacter pylori Infection

References

• Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716–27.
   PubMed Web of Science ®Google Scholar
• Unge P. What other regimens are under investigation to treat Helicobacter pylori infection? Gastroenterology 1997;113 Suppl: S131–48.
   Google Scholar
• van der Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1996;1:6–19.
   PubMedGoogle Scholar
• Labenz J, Stolte M, Ruhl GH, Becker T, Tillenburg B, Sollbohmer M, et al. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995;7:9–11.
   PubMed Web of Science ®Google Scholar
• Yousfi MM, el-Zimaity HM, al-Assi MT, Cole RA, Genta RM, Graham DY. Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9: 209–12.
   PubMed Web of Science ®Google Scholar
• Lind T, van Zantan SV, Unge P, Spiller R, Bayerdetörffer E, O’Morain C, et al. Eradication of Helicobacter pylori using one- week triple therapies combining omeprazole with two antimicrobials: the MACH 1 study. Helicobacter 1996;1: 138–44.
   Google Scholar
• Bazzoli F, Zagari M, Pozzato P, Valori O, Fossi S, Ricciardiello L, et al. Evaluation of short-term low-dose triple therapy for the eradication of Helicobacter pylori by factorial design in a randomized, double-blind, controlled study. Aliment Pharmacol Ther 1998;12:439–45.
   PubMed Web of Science ®Google Scholar
• The European Helicobacter pylori study group. Current European concepts in the management of Helicobacter pylori infection. The Masstricht Consensus Report. Gut 1997;41: 8–13.
   PubMedGoogle Scholar
• Lam SK, Talley NJ. Helicobacter pylori consensus. Report of the 1997 Asia Pacific consensus conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998;13: 1–12.
   Google Scholar
• Peitz U, Hackelsberger A, Malfertheiner P. A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy. Drugs 1999;57: 905–20.
   Google Scholar
• Graham KS, Malaty H, El-Zimaity HMT, Genta RM, Cole RA, Al-Assi MT, et al. Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Am J Gastroenterol 1995;90:1415–8.
   Google Scholar
• Labenz J, Rühl GH, Bertrams J, Börsch G. Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease. Aliment Pharmacol Ther 1994;8:323–7.
   PubMedGoogle Scholar
• van der Hulst RWM, Weel JFL, van der Ende A, ten Kate FJW, Dankert J, Tytgat GNJ. Therapeutic options after failed Helicobacter pylori eradication therapy. Am J Gastroenterol 1996;91:2333–7.
   PubMedGoogle Scholar
• Moreno JA, Pajares JM, Santander P, Carpintero P, Hermida C, Lara S, et al. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients. J Gastroenterol 1996;31 Suppl IX:48–52.
   Google Scholar
• Rinaldi V, Zullo A, Pugliano F, Valente C, Diana F, Attili AF. The management of failed dual or triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 1997;11:929–33.
   PubMedGoogle Scholar
• Ellenrieder V, Boeck W, Richter C, Marre R, Adler G, Glasbrenner B. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. Scand J Gastroenterol 1999;34:750–6.
   PubMed Web of Science ®Google Scholar
• Sheu BS, Wu JJ, Yang HB, Huang AH, Lin XZ. One-week proton pump inhibitor-based triple therapy eradicates residual Helicobacter pylori after failed dual therapy. J Formos Med Assoc 1998;97:266–70.
   Google Scholar
• Gisbert JP, Boixeda D, Bermejo F, Nieves Rincón M, Jesús Higes M, Angeles Arpa M, et al. Re-treatment after Helicobacter pylori eradication failure. Eur J Gastroenterol Hepatol 1999;11:1049–54.
   PubMed Web of Science ®Google Scholar
• Ström M, Sörberg M, Jönsson K-Å. Immediate repeat course of amoxycillin, metronidazole and omeprazole to eradicate Helicobacter pylori. Aliment Pharamacol Ther 1997;11:311–6.
   PubMedGoogle Scholar
• Moshkowitz M, Konikoff FM, Peled Y, Brill S, Hallake A, Tiomny E, et al. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. Aliment Pharamacol Ther 1996;10:1015–9.
   PubMed Web of Science ®Google Scholar
• Ali’ A, Menegatti M, Gatta L, Landi F, Ricci C, Acciardi C, et al. A second-line anti-Helicobacter pylori therapy in patients with previously failed treatment. Am J Gastroenterol 1999;94: 2321–3.
   Google Scholar
• Lerang F, Moum B, Haug JB, Berge T, Tolas P, Sandvei PK, et al. Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy. Scand J Gastroenterol 1997;32:1209–431.
   PubMed Web of Science ®Google Scholar
• Lee JM, Breslin NP, Hyde DK, Buckley MJ, O’Morain CA. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice. Aliment Pharamacol Ther 1999;13:489–96.
   Google Scholar
• Gisbert JP, Gisbert JL, Marcos S, Garcia Gravalos R, Carpio D, Pajares JM. Seven-day ‘rescue’ therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole. Aliment Pharamacol Ther 1999;13: 1311–6.
   Google Scholar
• Rinaldi V, Zullo A, De Francesco V, Hassan C, Winn S, Stoppino V, et al. Helicobacter pylori eradication with proton pump inhibitor-based triple therapies and re-treatment with ranitidine bismuth citrate-based triple therapy. Aliment Pharamacol Ther 1999;13:163–8.
   PubMed Web of Science ®Google Scholar
• Gomollon F, Ducons JA, Ferrero M, Garcia Cabezudo J, Guirao R, Simon MA, et al. Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple protonpump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases. Helicobacter 1999;4: 222–5.
   Google Scholar
• Atherton JC, Hawkey CJ, Spiller RC. Retreatment of Helicobacter pylori infection with amoxycillin and omeprazole in patients failing this regime is less successful than initial treatment (Abstract). Gastroenterology 1994;106:A42.
   Google Scholar
• Neville P, Axon A, Moayyedi P. Addition of metronidazole to omeprazole and amoxicillin for second line H. pylori eradication does not influence eradication rate: results of a single-blinded randomised trial (Abstract). Gastroenterology 1999;116:A266.
   Google Scholar
• van der Hulst RWM, Keller JJ, Weel J, Tytgat GNJ. Therapeutic options after failed H. pylori eradication therapy (Abstract). Gastroenterology 1996;110:A284.
   PubMedGoogle Scholar
• Matsukura N, Onda M, Okawa K, S Kato, H Hasegawa, T Yoshiyuki, et al. Two step therapy for H. pylori eradication with lansoprazole, amoxicillin and a mucosal protective agent: ecabet sodium (Abstract). Gastroenterology 1997;112:A214.
   Google Scholar
• Peitz U, Sulliga M, Nusch A, Wolle K, Leodolter A, Stolte M, et al. Randomised study on two second-line treatments after failed metronidazole-clarithromycin therapy (Abstract). GUT 1999;45:A114.
   Google Scholar
• Houben MHMG, van de Beek D, van’t Hoff BWM, van der Hulst RWM, Rauws EAJ, van der Ende A, et al. PPI-triple therapy failure in Helicobacter pylori (Hp) infection: retreatment with PPI-triple therapy or quadruple therapy (Abstract)? Digestion 1998;59: 413.
   Google Scholar
• Khatibian M, Soleimani HA, Mikaeli J, Malekzadeh R, Massarrat S. Effectiveness of 10 days omeprazole + clarithromycin + tinidazole (OCT) in patients who previously failed metronidazole based therapy (Abstract). Digestion 1998;59: 416.
   Google Scholar
• Lamarque D, Tankovic J, Berrhouma A, Sevin E, Delchier AJC. Triple therapy using ciprofloxacin for eradication of clarithromycin and metronidazole-resistant Helicobacter pylori (Abstract). GUT 1997;41:A104.
   Google Scholar
• Zala G, Flury R, Wüst J, Meyenberger Ch, Fried M, Wirth HP. Efficacy of triple therapy to eradicate H. pylori after failure of omeprazole/amoxicillin (Abstract). Gastroenterology 1995;108:A266.
   Google Scholar
• Gisbert JP, Marcos S, Gisbert JL, Carpio D, Valle J, Cabrera MM, et al. Rescue therapy after H. pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole (Abstract). Gastroenterology 1999;116:A172.
   Google Scholar
• Cudia B, Romano M, Gioe FP, Barbera N, Lo Gerfo D, Montalto R, et al. ‘Rescue’ therapy including ranitidine bismuth citrate (RBC) + minocycline (MIN) + amoxicillin (AMOX) for eradication of Helicobacter pylori (Hp) in previous Hp treatment failure (Abstract). GUT 1997;41:A103.
   Google Scholar
• Yakovenko A, Grigoriev P, Yakovenko E, Abazova F, Poliakov A, Agafonova N, et al. Ranitidine bismuth citrate (RBC)-based triple therapies for recurring Helicobacter pylori (Hp) eradication (Abstract). GUT 1999;45:A117.
   PubMedGoogle Scholar
• Di Mario F, Salandin S, Dal Bo N, Battaglia G, Pilotto A, Grassi SSA, et al. Retreatment after failure of Helicobacter pylori eradication: quadruple vs ranitidine bismuth citrate 2 weeks therapy (Abstract). Gastroenterology 1999;116:A149.
   PubMedGoogle Scholar
• Kusstatscher S, Dal BO N, Buda A, Salandin S, Rugge M, Cassaro G, et al. Two different approaches after failure of standard H. pylori eradication triple therapies (Abstract). GUT 1997;41:A98.
   Google Scholar
• Di Mario F, Battaglia G, Buda A, Dal BO N, Benvenuti ME, Salandin S, et al. Ranitidine bismuthate citrate as a second step for the eradication of Helicobacter pylori (Abstract). Gastroenterology 1998;114:A104.
   Google Scholar
• Borda F, Martinez A, Echarri A, Jimenez J, Rodriguez C, Jara C. Clinical practice results of quadruple treatment in Helicobacter pylori eradication failure with OCA-7 (Abstract). GUT 1998;43:A81.
   Google Scholar
• Huelin Benìtez J, Jimènez Perez M, Duràn Campos A, Espana Contreras P, De la Cruz Lombardo J, Lozano Rey JM, et al. Quadruple therapy with omeprazole, tetracycline, metronidazole, and bismuth as a second option after failure of a first eradication therapy (abstract). GUT 1998;43:A86.
   Google Scholar
• Goddard AF, Logan RPH, Atherton JC, Hawkey CJ, Spiller RC. Maastricht consensus report regimen for second-line treatment of H. pylori infection: how does it perform in practice (Abstract)? GUT 1997;41:A96.
   Google Scholar
• Michopoulos S, Bouzakis H, Vougadiotis I, Sotiropoulou M, Tsibouris P, Balta A, et al. Randomized study comparing omeprazole (O) and ranitidine (R) as antisecretory agent in ‘quad’ therapy provided as a second choice treatment in patients with duodenal ulcer (Abstract). Gastroenterology 1997;112:A219.
   Google Scholar
• Choi IJ, Park MJ, Kim YS, Kim JS, Jung HC, Song IS, et al. Comparison of the efficacy of two quadruple therapies for Helicobacter pylori eradication in patients with primary treatment failure (Abstract). Gastroenterology 1999;116:A137.
   Google Scholar
• Pieramico O, Zanetti MV. Treatment with quadruple therapy after triple therapy failure in patients infected with H. pylori resistant strains (Abstract). Gastroenterology 1999;116:A282.
   Google Scholar
• Michopoulos S, Tsibouris P, Sotiropoulou M, Bouzakis H, Balta A, Papaspyrou I, et al. Randomized comparison of omeprazole (O) and ranitidine (R) when used for H. pylori (HP) eradication in ‘quad’ treatment (second line) of patients with erosive duodenitis (ED) or duodenal ulcer (DU) (Abstract). GUT 1999;45:A118.
   Google Scholar
• Tjivras M, Balatsos V, Tsirantonaki M, Skandalis N, Archiman- dritis A. High eradication rate of Helicobacter pylori (HP) in patients unsuccessfully treated previously (Abstract). Gastroenterology 1997;112:A312.
   Google Scholar
• Seppälä K, Sipponen P, Nuutinen H, Färkkilä M, Anisimova S, Kosunen TU. Intent to treat metronidazole resistant H. pylori infection to 100% of cure. Therapy with quadruple therapy and its modification (Abstract). Gastroenterology 1995;108:A216.
   Google Scholar
• Borody TJ, Shortis NP, Chongnan J, Reyes E, O’Shea JE. Eradication failure (EF) after H. pylori treatment-further therapies (Abstract). Gastroenterology 1996;110:A67.
   Google Scholar
• Huang J-Q, Hunt RH. Treatment after failure: the problem of ‘non-responders’. Gut 1999;45:140–4.
   Google Scholar
• Dehesa M, Larisch J, Di Silvio M, Dibildox M, Almaguer I, Gonzalez G, et al. Comparison of three seven days pantoprazole (PANTO) based Helicobacter pylori (Hp) eradication schemes in a Mexican population with highly metronidazole (MET) resistant Hp strains (Abstract). Gastroenterology 1998;114:A99.
   Google Scholar
• Buckley MJ, Xia HX, Hyde DM, Keane CT, O’Morain CA. Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance. Dig Dis Sci 1997;42:2111–5.
   Google Scholar
• Miyaji H, Azuma T, Ito S, Suto H, Ito Y, Yamazaki Y, et al. Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan. Aliment Pharmacol Ther 1997;11:1131–6.
   PubMed Web of Science ®Google Scholar
• Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493–6.
   PubMed Web of Science ®Google Scholar
• Labenz J, Leverkus F, Borsch G. Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. Scand J Gastroenterol 1994;29:1070–5.
   Google Scholar
• Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993;88:405–9.
   Google Scholar
• Moayyedi P, Chalmers DM, Axon AT. Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. J Gastroenterol 1997;32: 24–7.
   PubMed Web of Science ®Google Scholar
• Labenz J, Gyenes E, Ruhl GH, Borsch G. Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study. GUT 1993;34:1167–70.
   PubMed Web of Science ®Google Scholar
• Labenz J, Gyenes E, Ruhl GH, Borsch G. Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993;88:491–5.
   PubMed Web of Science ®Google Scholar
• Sakurai K, Tanaka H, Yamaguchi Y, Yamada M, Kirihara K, Kojima T, et al. Importance of drug selection and the use of sensitivity tests for the eradication therapy for Helicobacter pylori (in Japanese with English abstract). Nippon rinsho 1999;57:76–80.
   Google Scholar
• Murakami K, Kimoto M. Antibiotic-resistant H. pylori strains in the last ten years in Japan (in Japanese with English abstract). Nippon rinsho 1999;57: 81–6.
   Google Scholar
• Aoyama N, Shirasaka D, Sakai T, Shirakawa K. Characteristics of anti-microbial agents and its clinical choice for H. pylori treatment: Nippon Rinsho 1999;57: 43–52.
   Google Scholar
• Sjostedt S, Sagar M, Lindberg G, Wikstrom B, Nord CE, Seensalu R. Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin. Scand J Gastroenterol 1998;33:39–43.
   PubMed Web of Science ®Google Scholar
• Labenz J, Stolte M, Blum AL, Jorias I, Leverkus F, Sollbohmer M, et al. Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin. GUT 1995;37:39–43.
   PubMed Web of Science ®Google Scholar
• Miehlke S, Mannes GA, Lehn N, Hele C, Stolte M, Bayerdorffer E. An increasing dose of omeprazole combined with amoxycillin cures Helicobacter pylori infection more effectively. Aliment Pharmacol Ther 1997;11:323–9.
   PubMed Web of Science ®Google Scholar
• Labenz J, Beker JA, Dekker CP, Farley A, Klor HU, Jonsson A. Doubling the omeprazole dose (40 mg b.d. vs. 20 mg b.d.) in dual therapy with amoxycillin increases the cure rate of Helicobacter pylori infection in duodenal ulcer patients. Aliment Pharmacol Ther 1997;11:512–22.
   Google Scholar
• Maconi G, Bordi C, Cesana B, Pilato FP, Damilano I, Franceschi M, et al. Dual therapy with high or low doses of omeprazole does not achieve an acceptable rate of Helicobacter pylori eradication in duodenal ulcer patients. A multicentre randomized long-term detailed study. Ital J Gastroenterol Hepatol 1997;29:501–6.
   Google Scholar
• de Boer WA, Tytgat GNJ. How to treat Helicobacter pylori infection—should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint. Eur J Gastroenterol Hepatol 1996;8:709–16.
   PubMedGoogle Scholar
• Perri F, Festa V Andriulli A. Treatment of antibiotic-resistant Helicobacter pylori. N Engl J Med 1998;339:53.
   PubMed Web of Science ®Google Scholar